Defining the Human Insulin Resistance Molecular Network; SIGNATURE
NCT ID: NCT07255807
Last Updated: 2025-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
80 participants
INTERVENTIONAL
2025-12-01
2038-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
Does the cause of insulin resistance vary between individuals due to their genes and lifestyle?
Can the investigators identify different types (sub-phenotypes) of insulin resistance at the molecular level?
Researchers will compare groups who either reduce their physical activity for 14 days or consume a high-fat diet for 3 days, to see how these changes affect insulin sensitivity and related biological markers.
Participants will:
* Complete a health screening and be assessed for eligibility
* Undergo baseline testing to measure insulin sensitivity, physical activity, diet, and metabolic health
* Be randomly assigned to one of two short-term interventions (14 days of reduced physical activity, or 3 days of a high-fat, high-calorie diet)
* Repeat selected tests after the intervention to assess changes
This study will help researchers better understand how lifestyle and biology interact in the development of insulin resistance, even in people who are otherwise healthy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Studies of Insulin and Diabetes
NCT00001987
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
NCT05165706
Reversal of Lipid-Induced Insulin Resistance
NCT02193295
Depletion of Liver Fat in Type 2 Diabetes
NCT06211556
Microvascular Dysfunction and the Development of Whole-body Insulin Resistance
NCT02628301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 80 healthy participants-40 males and 40 females aged between 25 and 55 years-will be recruited. All participants must have a body mass index (BMI) between 18 and 30 and meet strict inclusion and exclusion criteria to minimize confounding variables. Participants will be free of chronic disease, non-smokers, have limited alcohol intake, and not engage in high levels of physical activity. This controlled approach ensures a more accurate assessment of the variables under investigation.
At baseline, all participants will undergo comprehensive phenotyping, including assessments of habitual physical activity, dietary intake, glucose tolerance, and whole-body insulin sensitivity. This will allow the researchers to categorize sub-phenotypes of insulin resistance at both the physiological and molecular level.
Following baseline testing, 40 of the 80 participants will undergo one of two short-term interventions designed to stress metabolic pathways associated with insulin sensitivity:
* Reduced physical activity: Participants will significantly decrease their daily physical activity for 14 days.
* High-fat diet: Participants will consume a hypercaloric high-fat diet for 3 consecutive days.
The aim of these interventions is to test how short-term negative lifestyle changes impact insulin action and related molecular markers, and whether these responses vary between individuals with different phenotypic and genetic profiles.
After the intervention period, selected metabolic tests will be repeated to assess changes in insulin sensitivity and molecular signaling. The primary outcome measure is whole-body insulin action, assessed using gold-standard physiological methods. Exploratory outcomes include identifying cellular and molecular mechanisms contributing to insulin resistance, and understanding the interaction between gene expression and lifestyle responses.
By combining deep phenotyping with short-term interventions, this study will generate new insights into the biological diversity of insulin resistance. Ultimately, this may contribute to the development of more individualized strategies for the prevention and treatment of metabolic diseases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baseline Characterization
All participants (N=80) undergo extensive baseline characterization over three study visits. This includes assessments of insulin sensitivity, glucose tolerance, metabolic and physiological phenotyping, habitual physical activity, and dietary intake. No intervention is applied during this phase; the purpose is to establish baseline measures and characterize individual variation in insulin resistance and metabolic profiles.
Participants complete detailed clinical, physiological, and behavioral assessments without any experimental manipulation. This includes:
* Measurement of insulin action and glucose tolerance
* Dietary and physical activity profiling
* Collection of biospecimens for molecular analyses
No interventions assigned to this group
Lifestyle Interventions
A subset of 40 participants are randomized into one of two experimental interventions following baseline assessment:
* 14 days of reduced physical activity (\<1,500 steps/day), or
* 3 days of a hypercaloric high-fat diet
The aim is to evaluate how short-term lifestyle stressors affect insulin sensitivity and related molecular markers. Assessments from visits 4 and 5 are compared to baseline to determine within-subject changes.
Intervention Names:
1. Reduced Physical Activity
\- Participants limit daily steps to \<1,500 for 14 days
2. High-Fat Diet
* Participants consume a hypercaloric, high-fat diet for 3 days
Description of Intervention:
Participants undergo one of the two lifestyle interventions with strict monitoring and support. Selected baseline tests are repeated post-intervention to evaluate metabolic and molecular responses.
Physical Inactivity
Participants assigned to the physical inactivity intervention will reduce their daily physical activity to fewer than 1,500 steps per day for 14 consecutive days. This strict limitation significantly decreases overall movement and muscle activity, mimicking a sedentary lifestyle. The aim is to assess the short-term effects of reduced physical activity on insulin sensitivity and related metabolic processes. Compliance will be monitored using activity trackers and daily logs. Baseline metabolic and physiological assessments will be repeated after the intervention to evaluate changes.
Hypercaloric High-Fat Diet
Participants assigned to the high-fat diet intervention will consume a hypercaloric diet rich in fat for 3 consecutive days. The diet is designed to significantly increase caloric intake and fat consumption beyond habitual levels to induce short-term metabolic stress. This intervention aims to assess how a brief period of high-fat overfeeding affects insulin sensitivity and related molecular pathways. Participants' dietary intake will be carefully controlled and monitored to ensure adherence. Baseline metabolic and physiological assessments will be repeated after the intervention to evaluate changes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical Inactivity
Participants assigned to the physical inactivity intervention will reduce their daily physical activity to fewer than 1,500 steps per day for 14 consecutive days. This strict limitation significantly decreases overall movement and muscle activity, mimicking a sedentary lifestyle. The aim is to assess the short-term effects of reduced physical activity on insulin sensitivity and related metabolic processes. Compliance will be monitored using activity trackers and daily logs. Baseline metabolic and physiological assessments will be repeated after the intervention to evaluate changes.
Hypercaloric High-Fat Diet
Participants assigned to the high-fat diet intervention will consume a hypercaloric diet rich in fat for 3 consecutive days. The diet is designed to significantly increase caloric intake and fat consumption beyond habitual levels to induce short-term metabolic stress. This intervention aims to assess how a brief period of high-fat overfeeding affects insulin sensitivity and related molecular pathways. Participants' dietary intake will be carefully controlled and monitored to ensure adherence. Baseline metabolic and physiological assessments will be repeated after the intervention to evaluate changes.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI): 18-30 kg/m²
* Healthy (no diagnosed chronic diseases)
* Able and willing to comply with study procedures
Exclusion Criteria
* Alcohol intake exceeding 10 units per week
* Hemoglobin A1c (HbA1c) \> 48 mmol/mol (indicative of diabetes or prediabetes)
* Chronic diseases (e.g., cardiovascular disease, diabetes, etc.)
* Chronic medication use, including hormonal treatments
* High physical activity levels (more than 3 hours per week of moderate to vigorous exercise)
* Pregnancy or within 3 months postpartum
* Breastfeeding or within 3 months of cessation
* Abnormal routine blood markers (as defined in lab screening)
* Blood donation within the past 2 months
25 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sydney
OTHER
Queen Mary University of London
OTHER
Novo Nordisk A/S
INDUSTRY
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jorgen FP Wojtaszewski
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jørgen F.P. Wojtaszewski, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Copenhagen
Ylva Hellsten, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Copenhagen
Henriette Pilegaard, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
August Krogh Building
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NNF24OC0085866
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
SIGNATURE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.